Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
97.39
(
0.69%
)
Bitcoin
78,347.25
(
0.14%
)
News Focus
News Focus
Post# of 822485
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

FeMike

Send PM Follow Ignore
Followers 58
Posts 7682
Boards Moderated 0
Alias Born 02/05/2016

FeMike

Re: Nemesis18 post# 744067

Thursday, 01/16/2025 3:55:04 PM

Thursday, January 16, 2025 3:55:04 PM

Post# of 822485

As a result, it has never even come close to being considered at a CHM meeting


So just to be clear, it’s your belief that the drug referenced in the June CHM minutes was, in fact, a different brain cancer treatment? Can you enlighten me as to which other brain cancer treatment is currently under MHRA review?

CHM minutes from June said they considered:

"a medicine indicated to treat adults with brain cancer."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News